SCHEMBL26280685

SCHEMBL26280685

CC(C)=NNc1cnc2c(c1)n(-c1ccccc1)c(=O)n2C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.45
▸ MAPT P10636 6/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ TDP1 Q9NUW8 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ PKM P14618 1/20 0.40
▸ MAPK1 P28482 1/20 0.38
▸ PRKDC P78527 2/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ GAA P10253 3/20 0.37
▸ PGR P06401 1/20 0.37
▸ XDH P47989 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.35
▸ PARG Q86W56 1/20 0.35
▸ LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24130429 0.86 MAPT (0.45) GSK3BMAPTALDH1A1TDP1MAPK1
SCHEMBL26279899 0.85 HSD17B10 (0.50) MAPTALDH1A1TDP1KDM4EPKM
SCHEMBL26280613 0.79 MAPT (0.39) MAPTALDH1A1TDP1KDM4EPKM
SCHEMBL26280634 0.79 MAPT (0.41) GSK3BMAPTALDH1A1TDP1KDM4E
SCHEMBL26280658 0.78 MAPT (0.38) MAPTALDH1A1TDP1KDM4EPKM
SCHEMBL30349909 0.74 MAPK1 (0.48) GSK3BALDH1A1MAPK1PRKDCPIK3CA
SCHEMBL25407446 0.74 MAPK1 (0.48) GSK3BALDH1A1MAPK1PRKDCPIK3CA
SCHEMBL26280704 0.73 MAPT (0.38) MAPTALDH1A1TDP1KDM4EPKM
SCHEMBL26280865 0.73 MAPT (0.40) GSK3BMAPTALDH1A1TDP1KDM4E
SCHEMBL26280780 0.71 PRKDC (0.43) PRKDCPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT GSK3B 3251/4885MAPT 3518/4885ALDH1A1 1343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback